Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Talis Biomedical (TLIS).
Talis Biomedical Corporation has struck a retention deal with Interim CFO Rebecca Markovich, offering her $89,250 to stay on board through major corporate transitions like a sale, merger, or dissolution. This move, which will be detailed in the company’s upcoming quarterly report, aims to ensure financial leadership stability during pivotal moments for the company’s future.
Find detailed analytics on TLIS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue